Holen Sie sich die Stockscreener-App
8.28
0.60%
-0.05
Schlusskurs vom Vortag:
$8.33
Offen:
$8.46
24-Stunden-Volumen:
74,381
Relative Volume:
0.21
Marktkapitalisierung:
$268.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-12.57%
1M Leistung:
-21.22%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$7.90
$8.46
1-Wochen-Bereich:
$7.90
$9.5693
52-Wochen-Spanne:
$6.565
$13.47
Jade Biosciences Inc Stock (JBIO) Company Profile
Firmenname
Jade Biosciences Inc
Sektor
Branche
Telefon
617-443-2400
Adresse
930 WINTER STREET, WALTHAM
Vergleichen Sie JBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JBIO
Jade Biosciences Inc
|
8.28 | 268.53M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-14 | Eingeleitet | Jefferies | Buy |
| 2025-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2025-05-07 | Eingeleitet | Wedbush | Outperform |
| 2025-05-05 | Eingeleitet | Stifel | Buy |
| 2025-05-02 | Eingeleitet | TD Cowen | Buy |
| 2024-06-18 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-06-18 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-06-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-06-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-06-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-03-25 | Fortgesetzt | Jefferies | Buy |
| 2023-12-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-01 | Eingeleitet | Guggenheim | Buy |
| 2022-12-06 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Outperform |
| 2022-08-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-02-11 | Eingeleitet | BTIG Research | Buy |
| 2021-07-26 | Eingeleitet | Cowen | Outperform |
| 2021-07-26 | Eingeleitet | Evercore ISI | Outperform |
| 2021-07-26 | Eingeleitet | Jefferies | Buy |
| 2021-07-26 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Jade Biosciences Inc Aktie (JBIO) Neueste Nachrichten
Is Jade Biosciences Inc. stock overvalued or undervaluedHigh-yield market plays - jammulinksnews.com
What institutional investors are buying Jade Biosciences Inc. stockAccess exclusive market insights for free - jammulinksnews.com
What are the latest earnings results for Jade Biosciences Inc.Discover stocks with massive upside potential - jammulinksnews.com
How Resilient Is Jade Biosciences Inc. Stock During Economic DownturnsHigh Return Investment Tips - Newser
Jade Biosciences Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Access to Investment Community - Newser
Is Jade Biosciences Inc. a growth stock or a value stockReal-time trading signals for maximum returns - jammulinksnews.com
Is Jade Biosciences Inc. a Top Dividend Stock to Watch in 2025Low Drawdown Trade Signals - Newser
What makes Jade Biosciences Inc. stock price move sharplyRapid Gain Targets - Metal.it
How Jade Biosciences Inc. stock performs during market volatilityFree Risk Assessment Services - Newser
Jade Biosciences Inc. Stock Analysis and ForecastRecord-setting profit potential - PrintWeekIndia
How high can Jade Biosciences Inc. stock price go in 2025Powerful growth strategies - jammulinksnews.com
What analysts say about Jade Biosciences Inc. stockAccelerated wealth expansion - Autocar Professional
Is Jade Biosciences Inc. a good long term investmentExplosive portfolio gains - PrintWeekIndia
What drives Jade Biosciences Inc. stock priceUnstoppable profit momentum - PrintWeekIndia
Why Jade Biosciences Inc. stock is on top investor watchlistsFree Predictions - jammulinksnews.com
IGM Biosciences Inc. Stock Analysis and ForecastLightning-fast growth - Autocar Professional
Jade Biosciences appoints Brad Dahms as CFO - MSN
Why Jade Biosciences Inc. stock attracts strong analyst attentionReal Time Stock Signal - Newser
Finanzdaten der Jade Biosciences Inc-Aktie (JBIO)
Es liegen keine Finanzdaten für Jade Biosciences Inc (JBIO) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):